JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES) ›› 2015, Vol. 53 ›› Issue (3): 17-21.doi: 10.6040/j.issn.1671-7554.0.2014.779

Previous Articles     Next Articles

Expression of human papillomavirus late capsid protein 1 in CaSki cells

DU Yijiang, XIAO Changyi, YE Hong, TANG Guicheng, LI Jiahua   

  1. Department of Histology and Embryology, Medicine College of China Three Gorges University, Yichang 443002, Hubei, China
  • Received:2014-11-03 Revised:2015-01-23 Online:2015-03-10 Published:2015-03-10

PDF (PC)

396

Abstract: Objective To investigate the expression of human papil1omavirus (HPV) late capsid protein 1 (L1) in CaSki cells. Methods Using polyvalent HPV L1 mice monoclonal antibody as the probe, the L1 protein expression in CaSki cells was investigated by ELISA, immunohistochemistry and Western blotting. L1 mRNA expression was detected by RT-PCR. Results HPV L1 was strong positive in CaSki cells, indicating that L1 protein was expressed in CaSki cells. L1 mRNA was expressed in CaSki cells. Conclusion CaSki cells integrated HPV 16 DNA genome can express L1 protein.

Key words: Caski cells, Human papillomavirus, Uterine cervix cancer, Late capsid protein 1

CLC Number: 

  • R737.33
[1] Jemal A, Bray F, Center MM, et al. Global cancer statistics[J]. CA Cancer J Clin, 2011, 61(2):69-90.
[2] 李慧弘,肖长义,袁太宁,等.宫颈癌HeLa细胞内HPV L1蛋白表达的观察[J].中国免疫学杂志, 2013, 29(3):260-264. LI Huihong, XIAO Changyi, YUAN Taining, et al. The expression of human papillomaviurs late capsid protein 1 in Hela cells[J]. Chinese Journal of Immunology, 2013, 29(3):260-264.
[3] Baker CC, Phelps WC, Lindfren V, et al. Structural and transcriptional analysis of human papillomavirus type 16 sequences in cervical carcinoma cell lines[J]. J Virol, 1987, 61(4):962-971.
[4] Perez LO, Barbisan G, Ottino A, et al. Human papillomavirus DNA and oncogene alterations in colorectal tumors[J]. Pathol Oncol Res, 2010, 16(3):461-468.
[5] de Roda HA, Walboomers JM, van den Brule AJ, et al. The use of general primers GP5 and GP6 elongated at their 3' ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR[J]. J Gen Virol, 1995, 76 ( Pt 4):1057-1062.
[6] Jacobs MV, de Roda HA, van den Brule AJ, et al. Group-specific differentiation between high- and low-risk human papillomavirus genotypes by general primer-mediated PCR and two cocktails of oligonucleotide probes[J]. J Clin Microbiol, 1995, 33(4):901-905.
[7] Gravitt PE, Peyton CL, Alessi TQ, et al. Improved amplification of genital human papillomaviruses[J]. J Clin Microbiol, 2000, 38(1):357-361.
[8] Zhang T, Xu Y, Xu X, et al. Trivalent Human Papillomavirus (HPV) VLP vaccine covering HPV type 58 can elicit high level of humoral immunity but also induce interference among component types[J]. Vaccine, 2010, 28(19):3479-3487.
[9] Orozco JJ, Carter JJ, Koutsky LA, et al. Humoral immune response recognizes a complex set of epitopes on human papillomaviru stype 6 L1 capsomers[J]. Virol, 2005, 79(15):9503-9514.
[10] Nelson LM, Rose RC, Moroianu J. Nuclear import strategies of high risk HPV16 L1 major capsid protein[J]. Biol Chem, 2002, 277(26):23958-23964.
[11] Day PM, Kines RC, Thompson CD, et al. In vivo mechanisms of vaccine-induced protection against HPV infection[J]. Cell Host Microbe, 2010, 8(3):260-270.
[12] Wang XM, Cook JC, Lee JC, et al. Human papiL1omavirus type 6 virus-like particles present overlapping yet distinct conformational epitopes[J]. Gen Virol, 2003, 84(6):1493-1497.
[13] Wentzensen N, Ridder R, Klaes R, et al. Characterization of viral-cellular fusion transcripts in a large series of HPV16 and 18 positive anogenital lesions[J]. Oncogene, 2002, 21(3):419-426.
[14] Choi YS, Kang WD, Kim SM, et al. Human papillomavirus L1 capsid protein and human papillomavirus type 16 as prognostic markers in cervical intraepithelial neoplasia 1[J]. Int J Gynecol Cancer, 2010, 20(2):288-293.
[15] Lee H, Lee KJ, Jung CK, et al. Expression of HPV L1 capsid protein in cervical specimens with HPV infection[J]. Diagn Cytopathol, 2008, 36(12):864-867.
[16] Choi YS, Kang WD, Kim SM, et al. Human papillomavirus L1 capsid protein and human papillomavirus type 16 as prognostic markers in cervical intraepithelial neoplasia 1[J]. Int J Gynecol Cancer, 2010, 20(2):288-293.
[17] Steele JC, Roberts S, Rookes SM, et al. Detection of CD4(+)- and CD8(+)-T-cell responses to human papillomavirus type 1 antigens expressed at various stages of the virus life cycle by using an enzyme-linked immunospot assay of gamma interferon release[J]. J Virol, 2002, 76(12):6027-6036.
[18] Griesser H, Sander H, Hilfrich R, et al. Correlation of immunochemical detection of HPV L1 capsid protein in pap smears with regression of high-risk HPV positive mild/moderate dysplasia[J]. Anal Quant Cytol Histol, 2004, 26(5):241-245.
[19] Chambers G, Millan D, Cuschieri K, et al. Assessing the detection of human papillomavirus late mRNA in liquid base cytology samples for risk stratification of cervical disease[J]. J Med Virol, 2014, 86(4):627-633.
[20] Bin H, Ruifang W, Ruizhen L, et al. Detention of HPV L1 capsid protein and hTERC gene in screening of cervical cancer[J]. Iran J Basic Med Sci, 2013, 16(6):797-802.
[1] LIU Jingkang, YANG Jianyong, MENG Lihua, JIANG Jie. The value of serum miR-17-92 cluster in early diagnosis of HPV-positive cervical cancer [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(5): 86-90.
[2] LIU Ping1, XU Li2, SUN Yuan1, WANG Zhiping1. Prevalence and characteristics of human papillomavirus infection in pregnant women [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2014, 52(4): 107-112.
[3] ZHANG Xiao-Li, LI Xiao, WANG Xin, ZHENG Lin, DIAO Wei-Meng, JI Mei. null [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2009, 47(12): 17-20.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
Copyright 2018 © Editorial office of Journal of Shandong University (Health Sciences)
Supported by Beijing Magtech Co.Ltd